Related Experiment Video
Updated: May 9, 2026

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
A high throughput assay to identify modulators of Death Receptor 3 (DR3)
Emery Smith1, Joshua K Parker2, Izan Gonzalez Fayos1
1The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Department of Molecular Medicine, Jupiter, FL 33458, USA.
None:
Association of the TNF-like cytokine 1A (TL1A) with Death Receptor 3 (DR3) triggers a signaling cascade in T cells that results in the increased AP-1- and NF-κB-mediated expression of inflammation-promoting gene products. Dysregulation of TL1A/DR3 signaling is a major contributor to many autoimmune diseases, cancers, and other conditions yet there is a dearth of small molecule regulators of this pathway. Here we report a cell-based high throughput screen of 8000 compounds of compounds that yielded 12 antagonists but no agonists of this pathway.

